ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0961

Development of a Pain Sensitivity Index to Examine the Transition from Intermittent to Constant Pain in Knee Osteoarthritis: The Multicenter Osteoarthritis Study

Kosaku Aoyagi1, Lisa Carlesso2, S. Reza Jafarzadeh1, Michael LaValley3, Na Wang1, Laura Frey Law4, Beth Lewis5, Michael Nevitt6 and Tuhina Neogi1, 1Boston University School of Medicine, Boston, MA, 2McMaster University, Hamilton, ON, Canada, 3Boston University School of Public Health, Boston, MA, 4University of Iowa, Iowa City, IA, 5University of Alabama at Birmingham, Birmingham, 6University of California, San Francisco, San Francisco, CA

Meeting: ACR Convergence 2020

Keywords: Measurement, Osteoarthritis, pain

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Orthopedics, Low Back Pain, & Rehabilitation (0960–0964)

Session Type: Abstract Session

Session Time: 10:00AM-10:50AM

Background/Purpose: Alterations in nociceptive signaling, such as pain sensitization, which is an abnormal ascending pain facilitation, and/or inadequate descending pain modulation, are thought to be underlying mechanisms contributing to the transition from intermittent to constant pain in knee osteoarthritis (OA). Studies to date have primarily focused on individual measures of pain sensitivity, which can be assessed by quantitative sensory testing (QST). Whether combining pain sensitivity measures may provide better insights into the transition from intermittent to persistent pain than individual QST measures is not known. We therefore sought to develop a composite pain sensitivity index (PSI) based on QST measures that incorporates multiple aspects of nociceptive alterations and evaluated its relation to development of constant pain in knee OA.

Methods: We included subjects from the Multicenter Osteoarthritis (MOST) Study, a NIH-funded longitudinal cohort study of persons with or at risk of knee OA. We assessed Intermittent and Constant Osteoarthritis Pain (ICOAP) at baseline and two years later, and the following QST measures at baseline: i) pressure pain thresholds (PPT) at the wrist and patellae assessed with an algometer as the point at which pressure changed to slight pain; ii) temporal summation (TS) at the wrist using weighted probes; and iii) conditioned pain modulation (CPM) using PPT at the wrist as the test stimulus pre- and post-conditioning stimulus (forearm ischemia); CPM was computed as the post-PPT: pre-PPT ratio. Each QST measure was standardized and rescaled to 0-100 score, and then the PSI was created by taking the average of the summed scores of the four measures with equal weights, leading to PSI on a 0-100 scale. A lower PSI score represents greater pain sensitivity. Among participants at baseline who had intermittent pain of at least ‘mild’ severity occurring ‘sometimes’, we examined the relation of the PSI to the development of knee-specific constant pain by ICOAP two years later using logistic regression with GEE, adjusting for potential confounders. We repeated analyses for individual QST measures that were also standardized and rescaled to 0-100.

Results: 2737 participants (3031 knees) were included (mean age 64 ± 10, 58% female, mean BMI 29.4 ± 5.7). Over a two-year period, 6.7% developed constant pain. Each 10-unit increase in PSI score (signifying less pain sensitivity) was significantly associated with 33% lower odds of developing constant pain over 2 years (Table). In contrast, the magnitude of association for each individual QST measures was either smaller than that of the PSI score, or not associated with developing constant pain (Table).

Conclusion: The PSI score was associated with developing constant pain, whereas the individual QST measures had either smaller or null associations. This PSI score highlights the potential clinical relevance of multiple coexisting nociceptive signaling alterations to the pain experience in knee OA, and supports the importance of performing a global assessment of pain sensitization to capture the overall status of the nociceptive system.

Table: Relation of PSI Score vs. Individual QST to Developing of Constant Pain Over Two-year Period


Disclosure: K. Aoyagi, None; L. Carlesso, None; S. Jafarzadeh, None; M. LaValley, None; N. Wang, None; L. Frey Law, None; B. Lewis, None; M. Nevitt, None; T. Neogi, Lilly, 1, EMD Merck Serono, 1, Novartis, 1, Regeneron, 1, Pfizer/Lilly, 1.

To cite this abstract in AMA style:

Aoyagi K, Carlesso L, Jafarzadeh S, LaValley M, Wang N, Frey Law L, Lewis B, Nevitt M, Neogi T. Development of a Pain Sensitivity Index to Examine the Transition from Intermittent to Constant Pain in Knee Osteoarthritis: The Multicenter Osteoarthritis Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/development-of-a-pain-sensitivity-index-to-examine-the-transition-from-intermittent-to-constant-pain-in-knee-osteoarthritis-the-multicenter-osteoarthritis-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-a-pain-sensitivity-index-to-examine-the-transition-from-intermittent-to-constant-pain-in-knee-osteoarthritis-the-multicenter-osteoarthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology